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The aspartate and tyrosine aminotransferases from Escherichia
coli have 43% sequence identity and nearly identical active
sites. Both are equally good enzymes for dicarboxylate
substrates, but the latter transaminates aromatic amino acids
1000 times faster. In an attempt to discover the critical
residues for this differential substrate specificity, the aspartate
aminotransferase mutant V39L has recently been prepared.
It showed improved kcat/Km values for aspartate, glutamate
and tyrosine and the corresponding oxo acids, mainly due
to two to ten times lower Km values. For example, the Km
values of V39L (wild type) for Asp and Glu are 0.12 (1.0)
and 0.85 (2.7) mM respectively. The mutant was co-crystallized
with 30 mM maleate from both polyethylene glycol and
ammonium sulfate. Both structures were solved and refined
to /7-factors of 0.22 and 0.20 at 2.85 and 2.5 A resolution
respectively. They bear strong resemblance to the closed
structure of the wild type enzyme complexed with maleate.
The unexpected feature is that, for the first time, the closed
form was produced in crystals grown from ammonium
sulfate. It is concluded that the mutation has shifted the
conformational equilibrium towards the closed form, which
leads to generally reduced substrate Kms.
Key words: aspartate aminotransferase/conformational change/
enzyme specificity/point mutation/X-ray structure
Introduction
Aspartate aminotransferase (AspAT; EC 2.6.1.1) was the first
representative of the large family of vitamin B6-dependent
enzymes involved in nitrogen metabolism to be isolated in pure
form (Jenkins et al., 1959). Its properties have been thoroughly
investigated (Braunstein, 1973; Christen and Metzler, 1985;
Torchinsky, 1986; Jansonius and Vincent, 1987). AspATs are
a2-dimers with ~ 400 amino acid residues and one molecule of
the co-factor pyridoxal-5'-phosphate (PLP) per chain. It employs
a ping-pong bi-bi mechanism (Cleland, 1963) to catalyse the
reversible amino group transfer reaction L-aspartate + 2-oxo-
glutarate ±* oxaloacetate + L-glutamate in which the enzyme
shuttles between a PLP and a pyridoxamine-5'-phosphate (PMP)
form. Vertebrates contain two AspAT isozymes, a cytosolic
form (c Asp AT) with 411 or 412 residues per chain and a
mitochondrial form (mAspAT) with 401 residues per chain. The
best characterized bacterial AspAT is that of Escherichia coli
(eAspAT), the product of the aspC gene, with 396 residues per
chain. The many known sequences can be uniquely aligned due
to a high level of similarity (Christen and Metzler, 1985; Mehta
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et al., 1989) and it has become common praxis to use the residue
numbering of the first determined and longest sequence of pig
cytosolic AspAT (Ovchinnikov et al., 1973; Doonan et al., 1975)
throughout. The crystal structures of the cytosolic isozyme from
pig and chicken and of the chicken mitochondrial enzyme were
determined more than 10 years ago (reviewed in Christen and
Metzler, 1985; Torchinsky, 1986; Jansonius and Vincent, 1987).
Inhibitor binding studies revealed conformational changes
involving both the co-factor and die protein matrix and provided
the basis for proposals of the stereochemistry of the catalytic
reaction (Kirsch et al., 1984; Arnone et al., 1985a; Jansonius
and Vincent, 1987).
Interest in the catalytic mechanism of AspAT was further
enhanced when it became possible to determine the roles of
specific active site residues by kinetic studies of site-directed
mutants. Malcolm and Kirsch (1985), Toney and Kirsch (1987),
Kuramitsu et al. (1987), Cronin and Kirsch (1988) and Inoue
et al. (1989) are some early examples of these studies. Because
of the ease of expression of large quantities, e Asp AT mutants
were used in these studies in most cases. Naturally, this triggered
X-ray diffraction studies of the E.coli enzyme. Its structure was
solved independently by Kamitori et al. (1987, 1988, 1990), by
Smith et al. (1986, 1989) and by Jager et al. (1989). The fold
and the active site structure of eAspAT were found to correspond
closely to those of the vertebrate enzymes.
The two identical shared active sites of AspAT have evolved
to bind dicarboxylic acid substrates, mainly through hydrogen-
bonded ion pairs with active site arginines. The a-carboxylate
of the substrate interacts with Arg386 and its w-carboxylate with
Arg292 of the neighbouring subunit. Although significant catalytic
activity towards other amino acids would a priori seem
improbable, aromatic amino acids are (albeit poor) substrates for
AspAT (Shrawder and Martinez-Carrion, 1972; Mavrides and
Christen, 1978; Kuramitsu et al., 1990), with an efficiency
increasing in the order of eAspAT < mAspAT < eAspAT. Even
more intriguing are the catalytic properties of E. coli tyrosine
aminotransferase (eTyrAT, EC 2.6.1.5, the product of the tyrB
gene) in comparison with eAspAT. Sequence alignment shows
that these enzymes have 43% sequence identity, with all catalytic
and substrate binding residues of AspATs being conserved in
eTyrAT (Fotheringham et al., 1986). Thus, it is not surprising
that the latter is an equally efficient enzyme for dicarboxylic
acid substrates as the former (Powell and Morrison, 1978).
The puzzling feature is, how does eTyrAT manage to be diree
to four orders of magnitude more effective on aromatic amino
acids than eAspAT (Hayashi et al., 1993; Kohler et al., 1994)
despite the fact that all residues known to play a role in co-factor
or substrate binding and in catalysis in eAspAT are conserved
in eTyrAT (Fotheringham et al., 1986; Seville et al., 1988;
Jager et al, 1992)?
This intriguing phenomenon has, for several years, been the
subject of investigations in the laboratory of K.Kirschner
(Biozentrum, Basel). Seville et al. (1988) built models of both
eAspAT and eTyrAT using the refined structure of a complex
between mAspAT and maleate in space group C222, as a
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template (Jansonius et al., 1985; Jansonius and Vincent, 1987;
Picot et al., 1991). The enzyme in this complex adopts the closed
conformation. Seville et al. (1988) demonstrated that plausible
models of e Asp AT and eTyrAT could be built in this way,
essentially without changing the a-carbon skeleton of mAspAT.
Moreover, the substrate L-tyrosine could, as an 'external'
aldimine to PLP, be oriented in a productive conformation into
the active site of the closed eTyrAT model structure. This was
a further indication of the feasibility of the eTyrAT model. On
the basis of these models and prior to the existence of a crystal
structure of eAspAT, the residues of mAspAT, eAspAT and
eTyrAT at identical positions in and around the active site were
compared. This analysis enabled the design of mutant eAspATs
and eTyrATs with hybrid active sites (Kdhler, 1990; Kohler
et al., 1994). In this way attempts to find the key residue(s)
responsible for activity towards tyrosine and hydroxyphenyl-
pyruvate (HOPP) were made.
One promising candidate for such an exercise was residue 39
which is Ala in mAspAT, Val in eAspAT and Leu in eTyrAT.
Its bulkiness parallels activity towards aromatic amino and oxo
acid substrates. Accordingly, the V39L mutant eAspAT was
produced and characterized, in the hope that it would have
enhanced activity towards tyrosine. A kinetic analysis revealed
unexpected, but very interesting properties. Instead of being an
improved tyrosine aminotransferase, the mutant eAspAT was
generally a 'better' enzyme. The £cat values for the various
substrates were essentially identical to wild type eAspAT, but
the Km values were reduced by factors between two and ten,
with corresponding increases in kcJKm (which expresses substrate
specificity; Fersht, 1985). For example, Km and /ccat for the
substrates Asp and Glu (as determined for the half-reaction with
HOPP as oxo acid substrate) for V39L (in parentheses wild type)
are K^^ = 0.12(1.0) mM, kg?* = 85(68)/s, «<°lu) = 0.85
(2.7) mM and k(™u) = 243(220)/s (Kohler et al., 1994). The
same mutant was also studied by Hayashi et al. (1991) with
qualitatively similar results.
In order to investigate the structural basis for the curious effect
exerted by a single additional CH2-group, in a residue not in
direct contact with either substrate or co-factor (Jansonius and
Vincent, 1987; Seville etal., 1988; Jager, 1991), the V39L
mutant eAspAT was crystallized in collaboration with Kirschner
and colleagues (Jager et al., 1989) and the crystal structure of
a complex with the non-covalent inhibitor maleate was determined
using crystals of space group P2, grown with either polyethylene
glycol of average mol. wt 4000 (PEG) or ammonium sulfate as
precipitant. We describe here the results of that study and
show that the, for five out of six substrates (Kohler et al., 1994),
lowered Km values that characterize this mutant can, in all
likelihood, be attributed to a shift of the open-closed conforma-
tional equilibrium towards the closed structure.
Materials and methods
Cloning, mutagenesis and purification
The cloning, mutagenesis and expression of the aspC gene of
E.coli encoding eAspAT have been described by Fotheringham
et al. (1986). The construction, protein purification and bio-
chemical characterization of the V39L mutant enzyme was carried
out by E.Kohler and K.Kirschner [for details see Kohler (1991);
Kohler et al. (1994)]. In all cases eAspAT was produced in the
strain E.coli HW857 [F~A (aspC)Kar/tyrfl/Tn70], kindly pro-
vided by I.Fotheringham and M.Edwards.
Table I. Summary of crystallization and data collection
Code name
Ligand
Precipitant
Crystal size (mm)
Detector
Image width fi (°)
Exposure time (s)
Cell axes (a, b, c) (A)
Cell angle /3 (°)
Vm (A3/Da)b
Nc
Resolution limit (A)
Number of measurements
Number of unique data
«sym (/) (%)d
Completeness to resolution
limit (%)
V39L-PEG
30 mM maleate
31% (w/v) PEG40Q0
pH 7 5
1.8 x 0.5 x 0.5
XENTRON1CS
0.25
200
86.4 79.9 89.8
118.6
3.11
2
2.75
61 788
26 470
6.2
92.9
statistics
V39L-AS
30 mM maleate
48% saturated ASa
pH7.5
0.8 x 0.7 x 0 4
FAST
0.15
60
86.4 79.8 89.7
118.7
3.10
2
2.5
96 603
35 641
6.6
96.2
aAS, ammonium sulfate.
bRatio of volume of asymmetric unit to mol. wt (Matthews, 1968)
cNumber of subumts per asymmetric unit.
R =
where I
 hkl is the intensity from measurement j of reflection hkl and
<lhki> the m e a n v a l u e of j = \, . . ., N observations of symmetry
equivalent reflections hkl.
Crystallization, data collection and processing
Crystals were grown at pH 7.5 by the hanging drop method
(McPherson, 1982). The drops (20 jtl) contained 12.5 mg/ml
protein, 30 mM maleate and as precipitants either 12.5% (w/v)
PEG or 24% saturated ammonium sulfate in a 20 mM sodium
phosphate buffer, pH 7.5, with, as further additions, 1 mM each
of 2-oxoglutarate, EDTA, dithiothreitol, as well as 10 iM PLP
and 0.02% sodium azide. The wells contained 1 ml of either
23-25% PEG or 45-48% saturated ammonium sulfate in
20 mM sodium phosphate buffer, pH 7.5, in both cases.
The crystals belong to the monoclinic space group P2j with
unit cell parameters of typically a = 86.2, b = 79.8, c = 89.5 A
and /3 = 118.7°. Intensity data sets were collected on both
XENTRONICS and FAST area detector systems using graphite
monochromated CuKa radiation. Intensity data collected on the
XENTRONICS system were processed and reduced using the
XENGEN software (Howard et al., 1987). The data from the
FAST area detector system were processed using the MADNES
software (Messerschmidt and Pflugrath, 1987). Symmetry
equivalent reflections were averaged and merged giving final
/?sym-values of 6.2 and 6.6% for V39L-PEG and V39L-AS
respectively. Characteristics of the crystal forms and data
collection statistics are summarized in Table I.
Structure determination
The V39L-PEG structure was solved by molecular replacement,
using a modified chicken mAspAT structure (Eichele et al., 1979;
Ford et al., 1980) in which the side chains were exchanged to
conform to the eAspAT wild type sequence as a trial model
(Seville et al., 1988). Three regions where deletions occurred
within the eAspAT sequence compared with that of mAspAT
were found to be within surface loops of the molecule. The
rotational search was performed using the CCP4 programs
ALMN (by E.Dodson) and POLARRFN (by W.Kabsch), which
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are based on the fast rotation function (Crowther, 1972). The
dimeric trial model was positioned with its longest dimension
approximately parallel to the body diagonal of a PI unit cell with
axial lengths of a = b = c = 100 A and angles of 90°. Struc-
ture factors were calculated between 14 and 3 A, assuming an
overall temperature factor of 25 A2% The integration radius in
Patterson space was chosen to be 30 A (20 A for POLARRFN).
The translational search was performed using the program
TFSGEN (Tickle, 1985), which makes use of the T2-translation
function of Crowther and Blow (1967). Observed data between
15 and 3 A were included. After the initial structure solution,
rigid body refinement (CORELS, Sussman et al., 1977) was used
to further improve the V39L-PEG model. The second struc-
ture (V39L-AS) was interpreted by inspection of (F^ - F ^ ,
a:^ and ( 2 / ^ - F ^ , a ^ Fourier maps, in which the
calculated structure factors were taken from the refined
V39L-PEG structure.
Structure improvement
Interactive rebuilding. A Sim-weighted (2Fobs—Fcalc),acalc
electron density map for V39L-PEG was computed using the
calculated phases and structure factor amplitudes derived from
the rigid-body refined model. To reduce the bias towards the
model structure this electron density calculation was limited to
small portions of the molecule (typically 5-8%), for which the
contribution of calculated phases and structure factor amplitudes
were omitted. Using a local procedure (by J.P.Priestle, Basel)
these partial maps were merged to cover the molecule. In addition
to this 'omit' map, aa-weighted (2Fobs-/rca]c),acalc (Read, 1986)
and (3Fobs-2Fcalc),aca|C electron density difference maps were
calculated for simultaneous usage. The dimer was rebuilt on an
interactive Evans and Sutherland PS330 graphic display system
using FRODO software (Jones, 1985), extended by P.R.Evans
(MRC Cambridge, UK).
Least-squares refinement. Restrained least-squares refinement was
carried out using the program package TNT (Tronrud et al.,
1987). The weighting between the contributions from the
crystallographic and stereochemical terms was carefully adjusted
prior to positional refinement cycles by running test cycles using
the steepest descent method. No stereochemical restraints towards
deviation of torsional angles from ideal staggered conformations
were used during refinement, since the rotational energy barriers
between preferred side chain orientations are low.
Molecular dynamics refinement. Details of the different molecular
dynamics refinement steps are listed in Table n. After
determination of the ideal weights WA (stage 1 in Table U) the
V39L-PEG model was submitted to an energy minimization
procedure (XPLOR), including 8.0-3.0 A data, to relieve
structural stress. Two parallel runs of molecular dynamics
simulations using the simulated annealing technique were applied
to the model:
(i) dynamics simulation for 1.2 ps at 2000 K and a subsequent
300 fs fast cooling stage, including diffraction data between 8.0
and 3.0 A (stage 3a in Table II);
(ii) molecular dynamics simulation for 1.7 ps following the
slow cooling protocol, i.e. temperature bath coupled dynamics
from 2000 K to 300 K including diffraction data between 8.0
and 2.85 A (stage 3b in Table II).
The final stage (stages 4a and b in Table H) comprised 120 steps
of energy minimization.
Table n . Steps and parameters used in V39L-eAspAT simulated annealing
refinement
Stage Description
1 CHECK Determination of weight WA: WA = 420 000 kcal/mol
2 PREPARE 160 conjugate gradient steps energy minimization
CQ-restraints at 20 kcal/(mol A2), dF = 0.05 A
3(a) EQUILIBRATION 1.2 ps molecular dynamics, T = 2000 K,
and 10.0—3.0 A. integration step 1 fs, velocity scaling
FAST COOLING every 25 fs, dF = 0.2 A, followed by 0.3 ps
molecular dynamics, T = 300 K, 10.0-3.0 A,
integration step 1 fs, velocity scaling every 25 fs,
dF = 0.2 A, followed by
3(b) SLOW COOLING 1.7 ps temperature bath coupled molecular
dynamics, T = 2000-300 K, 10.0-2.85 A,
integration step 0.5 fs, WA = 390 000 kcal/mol,
dF = 0.2 A
4(a) FINAL 120 conjugate gradient steps energy minimization,
10.0-3.0 A, dF = 0.05 A
4(b) FINAL 120 conjugate gradient steps energy minimization,
10.0-2.85 A, dF = 0.05 A,
WA = 370 000 kcal/mol
Results
Structure solution and improvement
Different parameter combinations were tried in the rotational
search applied to the V39L-PEG data. The best signal to noise
ratio for the peaks found in the rotation function was obtained
using a Patterson integration radius of 5-30 A with data between
15 and 3 A included. The rotation matrix corresponding to the
highest peak in the rotation function was applied to the model
(the next highest peak had a height of 32 % of the maximum
rotation function value) and a translational search was performed
using the program TFSGEN. The highest peak was found to be
11 a above the mean (next highest peak 3.5 a). This gave a model
for which an /?-factor of 0.528 was calculated for the resolution
range of 15 — 3 A. An orthogonal translation vector of (x,y,z
= 22,0,11 A) was applied to the model. The y component of
the translation vector is arbitrary in space group P2j. A 2-D
fl-factor search (along x and z) in steps of 0.1 A around the
translation function solution lowered the /?-factor by 1%
(x,yj = 22.1,0,10.9 A). Using the program CORELS (Sussman
et al., 1977), the overall orientation, position and the dimer
structure of V39L-PEG eAspAT were improved by treating the
two monomers separately during rigid body refinement. The cen-
tre of gravity coordinates did not change in this process, while
rotations around the centre of the subunits were <2° . After
CORELS refinement, the model gave an /^-factor of 0.488 for
diffraction data between 15 and 3 A resolution. This preliminary
model was improved by rebuilding the positions that did not fit
well within the density of a Sim-weighted 'omit' map (see
Materials and methods).
The atomic positions of the corrected model were subjected
to 36 cycles of restrained least-squares refinement with the
program package TNT (Tronrud et al., 1987), interspersed with
manual rebuilding. This resulted in an ^-factor of 0.305 for the
data between 15.0 and 3.0 A resolution. The model was then
entered into XPLOR refinement. One hundred and sixty steps
of conjugate gradient energy minimization improved the overall
/?-factor to 0.252 for the data between 10.0 and 3.0 A resolution,
indicating that the errors in portions of the molecule had been
beyond the convergence range of the TNT refinement procedure.
The different simulated annealing refinement protocols (stages 3a
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Table m . Summary of refinement parameters and statistics
Parameter Structure
K-factor
Resolution range (A)
Number of atoms
Protein
Solvent
R.m.s. deviations from ideal geometry
Bond lengths (A)
Bond angles (°)
Torsion angles (°)
Planar groups (°)
Mean temperature factors (A2)
Overall
Large domain
Small domain
Backbone atoms
Side chain atoms
Solvent molecules
V39L-PEG
0.224
15-2.85
6250
6186
64a
0.015
2.984
24.627
1.838
25.8
22.4
33.6
19.6
29.8
V39L-AS
0.200
15-2.5
6392
6186
206
0.015
2.922
24.090
1 320
27.9
23.9
35.4
24.4
30.0
35.8
Subunit 1
R? )M
WKJK
KTrKS
aDue to limited resolution, manually inserted using graphics display system.
r|_eu39
.Leu3
10.0 6.67 5.00 4.00 3.33 2.86 2.50
Resolution (A)
Fig. 1. Variation in R-factor as a function of resolution (Luzzati plot). The
curves shown correspond to the V39L eAspAT - maleate complex structure
(V39L-PEG, open circles) and to that of the V39L eAspAT-maleate
complex crystallized from ammonium sulfate (V39L-AS, filled circles)
The dashed lines represent the theoretical variation of the /{-factor when
coordinate errors between Ar = 0.2 A and Ar = 0.45 A are assumed
(Luzzati, 1952).
and b in Table U) gave rise to structures of similar stereochemical
quality, but the lowest ^-factor was obtained with the slow cooling
protocol. A total of 64 water molecules could be located in the
final aa weighted (2/^)bs-Fcaic),aca|C electron density map. Posi-
tions and temperature factors of the solvent molecules were not
refined. Table HI summarizes the refinement parameters and the
final statistics of the V39L-PEG model.
The structure of the V39L-AS complex was solved by
difference Fourier techniques taking calculated structure amplitudes
and initial phases from the refined V39L-PEG model. The initial
^-factor for V39L-AS was 0.255 at 2.5 A. A total of 206
solvent molecules could be inserted in (Fobs-Fcalc),aca|C
difference Fourier maps. Three hundred steps of energy
minimization interspersed with 60 steps of individual temperature
factor optimization lowered the /{-factor to 0.20 including 35 130
reflections between 10.0 and 2.5 A (see Table HI).
Quality of the models
The (^ obs~ c^aic)»acaic difference maps are essentially featureless
and only few regions of the models have poorly defined
Subunit 2
Fig. 2. Ribbon drawing (Kraulis. 1991) of the overall structure of the V39L
eAspAT dimer in the closed conformation. The view is along the molecular
2-fold axis which is almost parallel to the c*-axis. The long helix
connecting the large and the small domains is kinked and serves as a pivot
for opening and closing of the enzyme during the catalytic cycle. The active
sites of the eAspAT dimer are located at the subunit interface and consist of
residues from both large domains and one of the small domains. The co-
factor PLP and the site of mutation (Val39 — Leu) are shown on both
subunits
(2Fobs-Fcak), aca,c electron density. These regions (residues
27 — 29 and 344—347) also exhibit very high temperature fac-
tors resulting in poor definition of side chain atomic positions.
The least flexible polypeptide segments in each subunit, as in-
dicated by the lowest temperature factors, occur in the large
pleated sheet, including the co-factor binding residues in the ac-
tive site region. The general quality of the models can be judged
from the overall coordinate errors (Luzzati, 1952), by plotting
the variation in the /?-factor as a function of resolution or by the
program SIGMAA (Read, 1986). Using SIGMAA, the r.m.s.
coordinate errors for the maleate complexes were determined to
be 0.45 and 0.42 A respectively, which is somewhat higher than
the errors derived from the Luzzati (1952) plot (Figure 1). Upon
superposition of the backbone atoms (N, Ca, C, O) good
agreement is found for the two refined structures. The r.m.s.
deviations are <0.46 A, which is in the range of the overall
coordinate errors. The r.m.s. deviation in the backbone atom
positions between the initial model built from a coordinate set
of chicken mAspAT (Seville et al., 1988) and the refined models
of V39L eAspAT is 1.23 A. The same differences (1.24 A) are
found if the V39L mutant structure (V39L —AS) is compared
to the X-ray structure of chicken mAspAT, complexed with
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maleate (Jansonius and Vincent, 1987). Maximum deviations of
~5 A occur in a loop around Met246 located at the surface
of the molecule.
The <j> and \j/ angles of all residues are in allowed areas of the
Ramachandran plot with the following exceptions (the same in
both subunits; the angles given refer to subunit 1): Phe377
(-113°, -137°, in a surface loop) and Ser296 (69°, -58° ,
involved in substrate binding). Four non-glycine residues lie in
the aL-region: Lys98 (58°, 49°), Hisl66 (60°, 58°) and Cysl92
(56°, 71°) which lie in surface loops, while Arg266 (62°, 83°)
is a co-factor binding residue. All these residues except Lys98
and Phe377 have well defined side chain density.
Discussion
Conformational state—comparison to wild type structure
The overall structure of the eAspAT V39L mutant, which appears
to be similar to those of the vertebrate AspAT isozymes (Ford
etal., 1980; Arnone et al., 1985b; Borisov et al., 1985;
Jansonius and Vincent, 1987) and to previously described
eAspAT structures (Kamitori etal., 1988, 1990; Smith et al.,
1989), is illustrated by a ribbon diagram (Kraulis, 1991) in Figure
2. Details of the fold and the domain structure of eAspAT have
been described previously (Kamitori et al., 1988, 1990; Smith
et al., 1989). Three structures of wild type eAspAT complexed
with sulfate, maleate and 2-methylaspartate in space group P2,
have been solved by X-ray crystallography (Jager et al., 1994)
using crystallization conditions that were also applied in the
crystallization of the V39L mutant enzyme. Both wild type
structures liganded with a substrate analogue, maleate or
2-methylaspartate, were found to be in the closed conformation,
whereas the 'unliganded' structure (complexed with a sulfate ion)
adopts a 'half-open' conformation (Smith etal., 1989). The
closing of the structures involves a 6° rotation of the small domain
(residues 16-46 and 330-409) towards the centre of the rigid
PLP binding domain. This causes a reorientation of the side
chains of Aspl5, Ilel7, Vall8, Ile37 and Arg386 in the active
site such that tight contacts to the substrate are established,
presumably prior to catalysis taking place.
Interestingly, the half-open form is not found in any of the
crystal structures of the V39L mutant enzyme, although several
crystallization experiments were designed to produce crystals of
the half-open form, e.g. by crystallization from an ammonium
sulfate buffer without maleate. UV crystal spectra and the 2.7 A
electron density map in the active site region (data not shown)
suggest that the binding pocket is occupied, presumably with
2-oxoglutarate, which was present in the crystallization buffer
at a concentration of ~ 1 mM. This result demonstrated a shift
in the conformational equilibrium towards the closed structure,
caused by the mutation V39L.
The site of mutation
In many aminotransferases, position 39 (pig eAspAT numbering)
is occupied by a hydrophobic residue: alanine is found in all
vertebrate mAspAT and eAspAT sequences while eAspAT has
a valine and both eTyrAT and Saccharomyces cerevisiae
histidinol phosphate aminotransferase have a leucine in this
position. By contrast, an aspartate is found in E.coli histidinol
phosphate aminotransferase and rat TyrAT (Mehta et al., 1989).
Residue 39 is part of a cluster of hydrophobic residues
('hydrophobic patch') located at the active site entrance above
the binding pocket. The hydrophobic patch comprises residues
Ilel7, Leul8, Ala21, Ile37, Gly38, Tyr40, Thr47, Tyr263,
Met359, Asn388, Ala390 and Asn69* and Tyr70* from the
Table IV. Nearest neighbours to Leu39 side chain atoms in structure
V39L-AS
Atom,
Leu39C51
Leu39 C{,
Leu39 C
Leu39 Ca
Atom,
Ue37 Cy2
Thr47 Cy
Asn69*CT
Asn69*N62
Asn69*O61
Tyr263 C T
Tyr263 cj ,
Tyr263 Ca2
Tyr263 Cel
Tyr263 C f
Asn69*N62
Asn69*C
7Tyr7O*C61
Tyr7O*C£l
Ile37 Cy2
De37 C
Thr47 C
7Asn69*NS2
Tyr263 C f
Distance r,y (A) in
subunit SI (S2)
4.4 (4.3)
4.2 (4.6)
3.7 (3.7)
2.7 (2.8)
4.3 (4.6)
3.8 (3.6)
3.7 (3.7)
3.7 (3.7)
3.6 (3.5)
3.6 (3.6)
3.6 (3.9)
4.3 (4.1)
3.9 (4.1)
4.1 (4.0)
4.4 (4.4)
4.1 (4.0)
4.3 (4.1)
4.0 (3.9)
4.5 (4.6)
An asterisk indicates a residue from the second subunit.
adjacent subunit (an asterisk indicates a residue from the
neighbouring subunit). The side chain of residue 39 is neither
in direct contact with the substrate nor catalytically important
in another way. Van der Waals contacts with neighbouring
residues in the structure V39L-AS are listed in Table IV. It is
interesting to note that in both conformational states of eAspAT
valine (wild type) or leucine 39 (mutant) make contacts with
residues 69* and 70* from the neighbouring subunit. The
orientation of the Asn69* side chain adapts to the bulkiness of
residue 39. Although a substitution of Val39 by Phe would
increase the size of the side chain in this position it is doubtful
whether this could be accommodated in the densely packed
hydrophobic environment. In this respect it is anticipated that
the bulkiness of Phe interferes with a complete closure of the
active site, in accord with experimental evidence that the V39F
mutant eAspAT is a somewhat less efficient enzyme than V39L
and wild type eAspAT (Hayashi et al., 1991). Model building
studies using the eAspAT V39L-maleate complex suggest that
the reduced performance of the V39F enzyme mainly originates
from steric effects of Phe39 on Ile37 and De73* and that Phe39
should have little effect on the structural and functional role of
Tyr70*, as was suggested by Hayashi et al. (1991). Ile37 is
rotated out of the active site in the unliganded enzyme (Figure
4). Upon substrate or competitive inhibitor binding, it rotates back
into the hydrophobic patch, thereby shielding the active site from
bulk solvent. Phe39 disorganizes the packing of hydrophobic
residues at the active site entrance. This results in an insufficient
shielding of the active site as Ile37 is unable to rotate back into
the hydrophobic patch and to fully obstruct the active site entrance
in the closed conformation. An alanine residue is found in position
39 in all sequences of the vertebrate cytosolic and mitochondrial
isozymes. The packing of Ala39 against neighbouring hydrophobic
residues, e.g. Val37 and unfavourable contacts with charged
residues, i.e. Arg41 and Glu69*, in the direct vicinity of the
/3-carbon atom of Ala39 preclude incorporation of larger
hydrophobic residues in these isozymes. By contrast, Asn69* in
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Fig. 3. Superposition of important active site residues in wild type (Jager et al., 1994) and V39L eAspAT-maleate complexes. Residues Ilel7 and Vall8 (not
shown), Ile37, Leu39 and Asn69* form a hydrophobic lid above the substrate binding pocket, shielding it from bulk solvent. The changes in the active site
topology due to the mutation V39L are minute. Replacement of the Val39 side chain by that of Leu causes a shift in the position of the Asn69* amide group
and a reorientation of the Ile37 side chain to optimize its contacts with Leu39. The van der Waals interactions between Cit and CM of Leu39 and residues
Asn69*. Tyr70* and Tyr263 are strengthening the subunit - subunit interactions and stabilizing the closed conformation. The wild type structure is depicted in
grey.
194 194
Fig. 4. Superposition of important active site residues in wild type (Jager et al., 1994) and V39L eAspAT—maleate complexes, both crystallized from
ammonium sulfate. Maleate is found in the substrate binding pocket of the mutant enzyme only. A sulfate ion is found in the active site of the wild type
enzyme that adopts the 'half open' conformation. Hence, sulfate is unable to trigger domain closure. In the closed structure (see Figure 3) Ile37 has nearly the
same positions in the wild type and V39L eAspAT. Upon domain opening Ile37 in the wild type eAspAT rotates by 110°. The mutant enzyme seems to bind
substrate analogues and, presumably, substrates better than wild type eAspAT. The mutation brings about a shift in the conformational equilibrium from the
open towards the closed conformation. The wild type structure is depicted in grey.
eAspAT and Leu69* in eTyrAT leave more space for bulkier
side chains, such as valine and leucine, to form a tight
hydrophobic lid above the active site.
Active site topology—comparison to wild type structure
The crystallization conditions with maleate as the substrate
analogue and PEG as precipitant resulted in fully closed structures
for both wild type and V39L mutant enzyme (V39L-PEG), as
already predicted from UV absorption spectra of enzyme/inhibitor
solutions and preliminary X-ray studies (Jager et al., 1989).
Changes in the orientation of side chains of active site residues
and in the position of the substrate analogue arising from the
replacement of valine by leucine are minute and within
experimental error. The r.m.s. deviation in hydrogen bonding
distances between maleate and its protein ligands in wild type
and mutant eAspAT is 0.2 A (Jager, 1991). Close van der Waals
interactions between the substrate analogue and hydrophobic side
chains such as Eel7, Vail8 and De37 are found in both structures.
The side chain amide group of residue Asn69* is in contact with
the side chain of Leu39. A shift of the side chain amide group
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of 0.4 A relative to the wild type enzyme structure is observed
(Figure 3). The contacts between Leu39 and residues Asn69*
and Tyr70* enhance interactions between the small domain of
one subunit and the large domain of its neighbour, thereby
stabilizing the closed conformation. Further differences only
occur in the mean temperature factor of the Ile37 side-chain
atoms, which was determined to be 28.9 A2 in the mutant and
37.6 A2 in the wild type enzyme. [Due to the limited resolution
of the X-ray diffraction data, temperature factors of the V39L-
maleate complex crystallized from PEG were not treated
independently but optimized using the option BGROUP ('grouped
temperature factors') in the X-PLOR program package.] The
mean overall temperature factor for the two crystal structures
of the V39L mutant is 27.9 A2, whereas the closed structure of
the wild type enzyme — maleate complex has a mean B-value of
33.1 A2. The difference in the side chain temperature factor
indicates reduced flexibility of De37 in the V39L-AS structure,
i.e. a stabilization of residues forming the hydrophobic lid on
the active site entrance.
Interestingly, the V39L eAspAT crystal form obtained from
Structure of AspAT mutant with increased activity
ammonium sulfate is found to be in the closed conformation with
a maleate ion bound to the substrate binding pocket. By contrast,
in co-crystallization experiments using identical conditions as
for V39L-AS the wild type enzyme adopts the half-open
conformation. In the wild type structure, the position of the
maleate carboxyl group interacting with Arg386 is occupied
instead by a sulfate ion (Figure 4) which is present in the
crystallization buffer approaching a concentration of 1.7 M. This
provides evidence that the mutant enzyme has a higher affinity,
i.e. a lower Kd, for maleate than wild type eAspAT. Sulfate,
although a competitive inhibitor for AspATs, is not able to trigger
the domain movement. These findings support the notion that
the mutation of Val39 to Leu causes a shift in the equilibrium
from the open towards the closed conformation. The positions
of the side chain atoms of residues 69* and 263 are slightly altered
with respect to the wild type enzyme structure due to a small
shift in the backbone of residues 37-39. Upon domain opening
the side chain of De37 is rotated by ~ 110° around an axis
through the Ca atoms of residues 36-38 (Figure 4), where it
snugly fits in a pocket formed by Asn34, Leu35, Asn388 and
Gly391 (not shown).
To summarize, the mutant V39L has been crystallized under
three different conditions. In all three cases the closed
conformation of the enzyme was stabilized. With ammonium
sulfate as the precipitant (which does not trigger domain closure
for wild type eAspAT), 30 mM maleate could successfully
compete with sulfate ions in more than 30-fold excess for binding
in the active site and, thus, cause domain closure. In the presence
of only 1 mM 2-oxoglutarate the closed conformation was also
stabilized. This behaviour of the V39L mutant is in striking
contrast to that of wild type eAspAT. The structural differences
between the wild type and mutant closed structures are minimal
and limited to the immediate environment of residue 39, while
maleate binds in exactly the same manner to both active sites
(Figure 4). Therefore, the only explanation that the present
structures offer for the improved catalytic properties of the V39L
mutant is the shift in the open-closed conformational equilibrium.
This causes decreases in Km values of factors between two and
ten for five out of six substrates measured (Kohler et al., 1994).
Only oxaloacetate does not change its already very small Km
value of 0.02 mM in the mutant enzyme, perhaps because it reacts
so avidly with the co-factor PMP that domain closure is irrele-
vant to the process of binding (Picot et al., 1991). This effect
of the mutation V39L is confirmed by the opposite behaviour
of the L39V mutant of eTyrAT, which results in increased Km
values (and slightly reduced &cat values) compared with
wild type eTyrAT (Kohler et al., 1994).
A comparison of the properties of wild type and V39L eAspAT
nicely illustrates the subtle structural features that determine the
enzyme's dynamic behaviour. It does not, however, explain the
difference in specificity between eAspAT and eTyrAT. The weak
binding of aromatic substrates to eAspATs [saturation of the
active site was not observed in eAspAT for Tyr and Phe, for
example (Hayashi et al., 1991; Kohler et al., 1994)] clearly
necessitates a significant further stabilization of the closed
structure in order to obtain Km values for aromatic substrates
<0.1 mM (Hayashi et al., 1993). However, there also have to
be mutations that are favourable only for aromatic amino and
keto acid substrates. That the effects of point mutations are not
necessarily additive, as e.g. double and triple mutants of eAspAT
studied by Kohler et al. (1994) demonstrate, is a complication.
Attempts to obtain multiple eAspAT mutants with properties more
similar to those of eTyrAT are nonetheless continuing in the
laboratory of K.Kirschner and, independently, in that of
J.F.Kirsch (UC, Berkeley).
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